RecruitingPhase 3NCT07067463
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Sponsor: Zenas BioPharma (USA), LLC
Kansas City, KS · Roeland Park, KS · +17 more sites
Multiple Sclerosis clinical trials in Kansas City, KS
11 recruiting multiple sclerosis studies with a site in Kansas City, KS.
All trials in Kansas City, KS · All Multiple Sclerosis trials
RecruitingPhase 2NCT06434571
Comparing Telehealth-Delivered CBT-I to Web-Based CBT-I to Enhance Sleep, Reduce Fatigue, and Promote Neuroprotection
Sponsor: University of Kansas Medical Center
Kansas City, KS
RecruitingPhase 3NCT07225504
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Sponsor: Novartis Pharmaceuticals
Kansas City, KS · +42 more sites
RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
Fairway, KS · Hays, KS · Kansas City, KS · +48 more sites
RecruitingPhase 2NCT06782490
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
Sponsor: Celgene
Kansas City, KS · +15 more sites
RecruitingPhase 1 / Phase 2NCT07477639
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
Sponsor: Tr1X, Inc.
Kansas City, KS · +7 more sites
RecruitingPhase 2NCT07002034
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Sponsor: Reunion Neuroscience Inc
Kansas City, KS · +31 more sites
RecruitingPhase 3NCT06846281
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Sponsor: Novartis Pharmaceuticals
Kansas City, KS · +43 more sites
RecruitingPhase 1 / Phase 2NCT06063850
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
Sponsor: UniQure Biopharma B.V.
Kansas City, KS · +17 more sites
RecruitingNot applicableNCT06394310
Dry Needling in Multiple Sclerosis
Sponsor: University of Kansas Medical Center
Kansas City, KS
Not yet recruitingPhase 1NCT07883590
A Study of LY3873862 in Participants With Sporadic or Familial Amyotrophic Lateral Sclerosis (ALS).
Sponsor: Eli Lilly and Company
Kansas City, KS · +2 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.